You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 104 No. 11, November 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  LABORATORY SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (75)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Uveitis Induced in Primates by Interphotoreceptor Retinoid-Binding Protein

Shigeto Hirose, MD; Toichiro Kuwabara, MD; Robert B. Nussenblatt, MD; Barbara Wiggert, PhD; T. Michael Redmond, PhD; Igal Gery, PhD

Arch Ophthalmol. 1986;104(11):1698-1702.


Abstract



• Interphotoreceptor retinoid-binding protein was found to be highly uveitogenic in primates. All six monkeys immunized with bovine interphotoreceptor retinoid-binding protein developed ocular inflammation. The main clinical changes were sheathing of retinal vessels and deep well-circumscribed yellow-white lesions. Histologic changes in the retina included shortening of the outer segments and foci of inflammation, which extended through all retinal layers. Particularly profound were the choroidal changes, such as severe inflammatory infiltration, which often formed focal granulomas with epithelioid and giant cells. Some granulomas had the structure of Dalen-Fuchs nodules. These structures and other histologic changes in the monkeys closely resemble those in uveitic conditions in humans, such as sympathetic ophthalmia or Vogt-Koyanagi-Harada syndrome. These findings show that antigen that localizes specifically in the retina may initiate an immunopathogenic process affecting mainly the choroid.



Author Affiliations



From the Laboratories of Immunology (Drs Hirose, Nussenblatt, and Gery), Ophthalmic Pathology (Dr Kuwabara), and Retinal Cell and Molecular Biology (Drs Wiggert and Redmond), National Eye Institute, National Institutes of Health, Bethesda, Md.


Footnotes



Accepted for publication May 22, 1986.

Reprint requests to Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bldg 10, Room 10N210, Bethesda, MD 20892 (Dr Hirose).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cytokines and Chemokines in Uveitis - Is there a Correlation with Clinical Phenotype?
Ooi et al.
Clin Med Res 2006;4:294-309.
ABSTRACT | FULL TEXT  

Immunologic Mechanisms of Uveitis: New Targets for Immunomodulation
Whitcup and Nussenblatt
Arch Ophthalmol 1997;115:520-525.
ABSTRACT  

32 Cases of Sympathetic Ophthalmia: A Retrospective Study at the National Eye Institute, Bethesda, Md, From 1982 to 1992
Chan et al.
Arch Ophthalmol 1995;113:597-600.
ABSTRACT  

Angiography With Fluorescein-Labeled Dextrans in a Primate Model of Uveitis
Lightman et al.
Arch Ophthalmol 1987;105:844-848.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.